Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2010 6
2011 37
2012 7
2013 4
2014 4
2015 1
2016 1
2017 1
2018 1
2019 2
2020 1
2023 1
2026 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

50 results

Results by year

Filters applied: . Clear all
Page 1
Short-term vs conventional glucocorticoid therapy in acute exacerbations of chronic obstructive pulmonary disease: the REDUCE randomized clinical trial.
Leuppi JD, Schuetz P, Bingisser R, Bodmer M, Briel M, Drescher T, Duerring U, Henzen C, Leibbrandt Y, Maier S, Miedinger D, Müller B, Scherr A, Schindler C, Stoeckli R, Viatte S, von Garnier C, Tamm M, Rutishauser J. Leuppi JD, et al. Among authors: bodmer m. JAMA. 2013 Jun 5;309(21):2223-31. doi: 10.1001/jama.2013.5023. JAMA. 2013. PMID: 23695200 Clinical Trial.
DESIGN, SETTING, AND PATIENTS REDUCE: (Reduction in the Use of Corticosteroids in Exacerbated COPD), a randomized, noninferiority multicenter trial in 5 Swiss teaching hospitals, enrolling 314 patients presenting to the emergency department with acute COPD exacerbation, past or p …
DESIGN, SETTING, AND PATIENTS REDUCE: (Reduction in the Use of Corticosteroids in Exacerbated COPD), a randomized, noninferiority multicente …
Effect of Laparoscopic Sleeve Gastrectomy vs Laparoscopic Roux-en-Y Gastric Bypass on Weight Loss in Patients With Morbid Obesity: The SM-BOSS Randomized Clinical Trial.
Peterli R, Wölnerhanssen BK, Peters T, Vetter D, Kröll D, Borbély Y, Schultes B, Beglinger C, Drewe J, Schiesser M, Nett P, Bueter M. Peterli R, et al. Among authors: drewe j. JAMA. 2018 Jan 16;319(3):255-265. doi: 10.1001/jama.2017.20897. JAMA. 2018. PMID: 29340679 Free PMC article. Clinical Trial.
DESIGN, SETTING, AND PARTICIPANTS: The Swiss Multicenter Bypass or Sleeve Study (SM-BOSS), a 2-group randomized trial, was conducted from January 2007 until November 2011 (last follow-up in March 2017). Of 3971 morbidly obese patients evaluated for bariatric surgery at 4 S …
DESIGN, SETTING, AND PARTICIPANTS: The Swiss Multicenter Bypass or Sleeve Study (SM-BOSS), a 2-group randomized trial, was conducted from Ja …
Roflumilast--a phosphodiesterase-4 inhibitor licensed for add-on therapy in severe COPD.
Taegtmeyer AB, Leuppi JD, Kullak-Ublick GA. Taegtmeyer AB, et al. Swiss Med Wkly. 2012 Jul 25;142:w13628. doi: 10.4414/smw.2012.13628. eCollection 2012. Swiss Med Wkly. 2012. PMID: 22833385 Free article. Review.
Roflumilast is a selective phosphodiesterase 4 inhibitor which has been licensed in the European Union since 2010 and in Switzerland since November 2011 as an add-on treatment for patients with chronic obstructive pulmonary disease (COPD) in GOLD (Global Initiative for Chr …
Roflumilast is a selective phosphodiesterase 4 inhibitor which has been licensed in the European Union since 2010 and in Switzerland since N …
Pre-treatment comorbidities, C-reactive protein and eosinophil count, and immune-related adverse events as predictors of survival with checkpoint inhibition for multiple tumour entities.
Mehra T, Dongre K, Boesing M, Frei P, Suenderhauf C, Zippelius A, Leuppi JD, Wicki A, Leuppi-Taegtmeyer AB. Mehra T, et al. Among authors: leuppi taegtmeyer ab. Cancer Med. 2023 Jun;12(11):12253-12262. doi: 10.1002/cam4.5919. Epub 2023 Apr 21. Cancer Med. 2023. PMID: 37084178 Free PMC article.
METHODS: We performed a single-centre, retrospective, observational study including patients who received CPIs from 2011 to 2018 and followed until 2021. The primary outcome was overall survival, and the secondary outcome was the development of irAEs. ...
METHODS: We performed a single-centre, retrospective, observational study including patients who received CPIs from 2011 to 2018 and …
Active animal health surveillance in European Union Member States: gaps and opportunities.
Bisdorff B, Schauer B, Taylor N, Rodríguez-Prieto V, Comin A, Brouwer A, Dórea F, Drewe J, Hoinville L, Lindberg A, Martinez Avilés M, Martínez-López B, Peyre M, Pinto Ferreira J, Rushton J, VAN Schaik G, Stärk KD, Staubach C, Vicente-Rubiano M, Witteveen G, Pfeiffer D, Häsler B. Bisdorff B, et al. Among authors: drewe j. Epidemiol Infect. 2017 Mar;145(4):802-817. doi: 10.1017/S0950268816002697. Epub 2016 Dec 12. Epidemiol Infect. 2017. PMID: 27938416 Free PMC article.
Under the EU-FP7 project RISKSUR, a survey was conducted in 11 EU Member States and Switzerland to describe active surveillance components in 2011 managed by the public or private sector and identify gaps and opportunities. Information was collected about hazard, target po …
Under the EU-FP7 project RISKSUR, a survey was conducted in 11 EU Member States and Switzerland to describe active surveillance components i …
Acute calcineurin inhibitor overdose: analysis of cases reported to a national poison center between 1995 and 2011.
Ceschi A, Rauber-Lüthy C, Kupferschmidt H, Banner NR, Ansari M, Krähenbühl S, Taegtmeyer AB. Ceschi A, et al. Among authors: taegtmeyer ab, krahenbuhl s. Am J Transplant. 2013 Mar;13(3):786-95. doi: 10.1111/j.1600-6143.2012.04347.x. Epub 2012 Dec 27. Am J Transplant. 2013. PMID: 23279718 Free article.
This study investigated the circumstances, pharmacokinetics and outcomes of overdose with cyclosporine and tacrolimus reported to the Swiss Toxicological Information Centre between 1995 and 2011. Of 145,396 reports by healthcare professionals, 28 (0.02%) concerned enteral …
This study investigated the circumstances, pharmacokinetics and outcomes of overdose with cyclosporine and tacrolimus reported to the Swiss …
50 results